blog | TRex Bio

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, 2026, TRex Bio

TRex Bio (TRXB) Eyes $125 Million IPO to Advance Immune-Restoring Therapies

Eric Friedman

Oct 5, 2026, 4:05:47 PM

Subscribe to our Newsletter

Email

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.